Published Date: 31-Dec-2019
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Europe Biosurgery Market, published by KBV Research, the Europe Biosurgery Market would witness market growth of 6% CAGR during the forecast period (2019-2025).
The Germany market dominated the Europe Soft Tissue Attachments Biosurgery Market by Country in 2018. The UK market would grow at a CAGR of 6.5% during (2019 - 2025). Additionally, The France market is projected to witness a CAGR of 8.1% during (2019 - 2025).
The General Surgeries market dominated the Spain Biosurgery Market by Application in 2018, thereby, achieving a market value of $100.8 million by 2025. The Orthopedic Surgeries market is anticipated to witness a CAGR of 7.1% during (2019 - 2025). Additionally, The Neurological Surgeries market is estimated to grow at highest CAGR of 8.9% during (2019 - 2025).
The Surgical sealants market dominated the Italy Biosurgery Market by Product in 2018, growing at a CAGR of 6.9 % during the forecast period. The Soft Tissue Attachments market would witness a CAGR of 9.4% during (2019 - 2025). The Bone Graft Substitutes market is anticipated to witness a CAGR of 9.2% during (2019 - 2025). Additionally, The Adhesion Barriers market is exhibiting prominent CAGR of 8.9% during (2019 - 2025).
Structural Insights: https://www.kbvresearch.com/europe-biosurgery-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Baxter International, Inc., Johnson and Johnson, Medtronic PLC, Pfizer, Inc., Stryker Corporation, B. Braun Melsungen AG, Sanofi S.A., Becton, Dickinson and Company, Integra LifeSciences Holdings Corporation and CSL Limited.
Unique Offerings from KBV Research